header logo image

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

August 25th, 2024 2:46 am

REDWOOD CITY, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference in New York, NY.

Excerpt from:
Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Related Post

Tags:

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick